Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1997 6
1998 4
1999 12
2000 18
2001 17
2002 33
2003 39
2004 61
2005 62
2006 69
2007 54
2008 76
2009 71
2010 83
2011 74
2012 93
2013 79
2014 81
2015 96
2016 74
2017 100
2018 76
2019 93
2020 104
2021 107
2022 138
2023 133
2024 136
2025 182
2026 99

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,034 results

Results by year

Filters applied: . Clear all
Page 1
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H, Chiovato L, Nappi RE. Cena H, et al. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2695-709. doi: 10.1210/clinem/dgaa285. J Clin Endocrinol Metab. 2020. PMID: 32442310 Free PMC article. Review.
Obese women show poorer reproductive outcomes regardless of the mode of conception, and higher body mass index (BMI) is associated with poorer fertility prognosis. Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility, and many w …
Obese women show poorer reproductive outcomes regardless of the mode of conception, and higher body mass index (BMI) is associated with poor …
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
Fruzzetti F, Perini D, Russo M, Bucci F, Gadducci A. Fruzzetti F, et al. Gynecol Endocrinol. 2017 Jan;33(1):39-42. doi: 10.1080/09513590.2016.1236078. Epub 2016 Nov 3. Gynecol Endocrinol. 2017. PMID: 27808588 Clinical Trial.
Insulin resistance (IR) plays a pivotal role in PCOS. Insulin-sensitizer agents such as metformin and inositols have been shown to improve the endocrine and metabolic aspects of PCOS. The purpose of this study is to compare their effects on the clinical and m …
Insulin resistance (IR) plays a pivotal role in PCOS. Insulin-sensitizer agents such as metformin and inositols have been show …
A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome.
Nazirudeen R, Sridhar S, Priyanka R, Sumathi B, Natarajan V, Subbiah E, Raghavan KS, Sangumani J. Nazirudeen R, et al. Clin Endocrinol (Oxf). 2023 Aug;99(2):198-205. doi: 10.1111/cen.14931. Epub 2023 Jun 2. Clin Endocrinol (Oxf). 2023. PMID: 37265016 Clinical Trial.
OBJECTIVE: Insulin resistance and hyperinsulinemia plays an important role in pathogenesis of polycystic ovary syndrome (PCOS). Metformin, Myoinositol and d-chiro-inositol acts as insulin sensitizers and exerts a beneficial effects in PCOS …
OBJECTIVE: Insulin resistance and hyperinsulinemia plays an important role in pathogenesis of polycystic ovary syndrome …
Polycystic ovarian syndrome-current pharmacotherapy and clinical implications.
Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, Amin F, Bader GN. Rashid R, et al. Taiwan J Obstet Gynecol. 2022 Jan;61(1):40-50. doi: 10.1016/j.tjog.2021.11.009. Taiwan J Obstet Gynecol. 2022. PMID: 35181044 Free article. Review.
Polycystic ovary syndrome (PCOS), the most common endocrinopathy in women is characterized by polycystic ovaries, chronic anovulation and hyperandrogenism. ...However, the management of PCOS is challenging and current interventions are no …
Polycystic ovary syndrome (PCOS), the most common endocrinopathy in women is characterized by polycystic …
Single-cell profiling of the human endometrium in polycystic ovary syndrome.
Eriksson G, Li C, Sparovec TG, Dekanski A, Torstensson S, Risal S, Ohlsson C, Hirschberg AL, Petropoulos S, Deng Q, Stener-Victorin E. Eriksson G, et al. Nat Med. 2025 Jun;31(6):1925-1938. doi: 10.1038/s41591-025-03592-z. Epub 2025 Mar 20. Nat Med. 2025. PMID: 40114027 Free PMC article.
Polycystic ovary syndrome (PCOS) has a negative effect on the receptivity of the endometrium to embryo implantation and increases the risk of miscarriage and endometrial cancer. ...In addition, potential therapeutic targets such as integrin inhibitors …
Polycystic ovary syndrome (PCOS) has a negative effect on the receptivity of the endometrium to embryo implantat …
Endometrial function in women with polycystic ovary syndrome: a comprehensive review.
Palomba S, Piltonen TT, Giudice LC. Palomba S, et al. Hum Reprod Update. 2021 Apr 21;27(3):584-618. doi: 10.1093/humupd/dmaa051. Hum Reprod Update. 2021. PMID: 33302299 Free article. Review.
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. An endometrial component has been suggested to contribute to subfertility and poor reproductive outcomes in affected women. ...Among several interventions …
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. An endometrial …
Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management.
Manique MES, Ferreira AMAP. Manique MES, et al. Rev Bras Ginecol Obstet. 2022 Apr;44(4):425-433. doi: 10.1055/s-0042-1742292. Epub 2022 May 27. Rev Bras Ginecol Obstet. 2022. PMID: 35623621 Free PMC article.
Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging since normal pubertal development overlap typical features of this syndrome. ...Lifestyle interventions are the first-line treatment. Combined oral contraceptives, …
Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging since normal pubertal development …
Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome.
Xing C, Zhao H, Zhang J, He B. Xing C, et al. Front Endocrinol (Lausanne). 2022 Aug 17;13:945609. doi: 10.3389/fendo.2022.945609. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060969 Free PMC article. Clinical Trial.
OBJECTIVE: To observe the effect of metformin (MET) monotherapy versus MET plus liraglutide (LIRA) on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome (PCOS). ...CONCLUSIONS: In overweight patients with PCO …
OBJECTIVE: To observe the effect of metformin (MET) monotherapy versus MET plus liraglutide (LIRA) on gonadal and metabolic profiles …
Probiotic vs. placebo and metformin: probiotic dietary intervention in polycystic ovary syndrome - A randomized controlled trial.
Borzan V, Riedl R, Obermayer-Pietsch B. Borzan V, et al. BMC Endocr Disord. 2023 Apr 17;23(1):82. doi: 10.1186/s12902-023-01294-6. BMC Endocr Disord. 2023. PMID: 37062834 Free PMC article. Clinical Trial.
BACKGROUND: Polycystic Ovary Syndrome (PCOS) is a very common endocrine disorder with a variety of symptoms. ...If successful, this new therapy approach could open a new realm of possibilities for treating PCOS. To our knowledge, this is the fir …
BACKGROUND: Polycystic Ovary Syndrome (PCOS) is a very common endocrine disorder with a variety of symptoms. ... …
Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Zeng X, et al. Clin Chim Acta. 2020 Mar;502:214-221. doi: 10.1016/j.cca.2019.11.003. Epub 2019 Nov 13. Clin Chim Acta. 2020. PMID: 31733195 Review.
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease characterized by clinical or laboratorial hyperandrogenism, oligo-anovulation and metabolic abnormalities, including insulin resistance, excessive weight or obesity, type …
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease characterized by clinical or l …
2,034 results